Don’t switch medicines without support

Patients with common conditions such as rheumatoid arthritis, psoriasis and ulcerative colitis are being switched to new medicines without receiving the support they need to...

AI to help find new heart drugs

Researchers at Imperial are partnering with Bayer Pharmaceuticals to explore how artificial intelligence (AI) can accelerate the discovery of new drugs for heart conditions. An...

Safety concerns around aluminium adjuvants

It is approximately 10 years since we began our investigations into aluminium adjuvants and specifically their mode of action. We have reviewed the field in...

Palbociclib targets advanced breast cancer

Combining a targeted drug, palbociclib with hormone therapy substantially extends survival for women with advanced breast cancer, according to a major new study published in...

Cannabis is fuelling psychoses

New NHS figures showed there were 125,290 cannabis and spice-related hospital admissions in England from April 2013 to March 2018, including 14,888 under-20s. Consultant psychiatrist...

Time to act on secondary breast cancer

It's time to act on secondary breast cancer which is the stage when breast cancer spreads to other parts of the body and sadly becomes...